Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In the phase 2 clinical trial of retatrutide for adults with obesity (without type 2 diabetes), a clear dose-dependent response was observed between the administered dose and weight loss outcomes
That's a free T four
The first few weeks are the ones in which the medication has the greatest effect
Starting BMI and weight loss goal Metabolic health, including prediabetes, diabetes, insulin resistance, fatty liver, or PCOS Blood pressure, heart rhythm history, anxiety, and sleep issues Reflux or GERD history Preference for pills versus injections Side effect tolerance, including nausea, constipation, insomnia, or jitteriness Insurance coverage, self-pay cost, and pharmacy access History of bariatric surgery or weight regain after surgery Bottom line The right plan is the one you can tolerate, afford, and follow while your progress and safety are monitored over time
Rashki GhalenoLAlizadehADrevetJRShahverdiAValojerdiMR
Results Four studies comprising 219 patients pre-treatment and 216 post-treatment were included
US$ 27.45
US$ 27.92
US$ 29.77
US$ 22.85
US$ 23.58
US$ 27.28
